Prevention of cardiovascular disease risk and improve exercise performance in healthy subjects. Other general examinations
Conditions
Interventions
Intervention 1: Intervention with l- arginine supplementation (2 g per day) in 45 days in the intervention group. L-arginine pills is 1 gram & athletes take 2 tablets daily. Intervention 2: Placebo (2
Treatment - Drugs
Placebo
Intervention with l- arginine supplementation (2 g per day) in 45 days in the intervention group. L-arginine pills is 1 gram & athletes take 2 tablets daily.
Placebo (2 g per day) in 45 days in the control group. Malto dextrin pills is 1 gram & athletes take 2 tablets daily.
Sponsors
Research Deputy of Isfahan University of Medical Sciences
Isfahan University of Medical Science
Assistance Reaserch of Isfahan University of Medical Science
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included: 18-35 years old males; willing to participate in study; no smoking and alcohol; history of continuous exercise at least twice a week in a years ago; no consumption dietary supplement in the last two months; lack of history of acute or chronic disease. Exclusion criteria: failure to follow of intervention; consumption of any dietary supplements in duration of study; catching acute or chronic disease during intervention.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance. Timepoint: Before& after 45 intervention. Method of measurement: Harvard Step Test.;Sodium, potassium, fasting blood glucose and lipid profile. Timepoint: Before& after 45 intervention. Method of measurement: Blood tests.;Blood Pressure. Timepoint: Before& after 45 intervention. Method of measurement: Mercurial pressure gauge.;Body composition. Timepoint: Before& after 45 intervention. Method of measurement: Body composition analyser. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaseh Pahlavani
Student
Outcome results
None listed